Safety and efficacy of thalidomide in patients with myelofibrosis with myeloid metaplasia. [electronic resource]
- British journal of haematology Jul 2001
- 78-83 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0007-1048
10.1046/j.1365-2141.2001.02918.x doi
Adult Aged Aged, 80 and over Angiogenesis Inhibitors--adverse effects Fatigue--chemically induced Feasibility Studies Female Follow-Up Studies Humans Leukocyte Count Male Middle Aged Neutropenia--chemically induced Platelet Count Primary Myelofibrosis--complications Thalidomide--adverse effects